Risk & Side Effects What are the potential side effects of chelation therapy
30 minutes for non-DAC Standard dose (DAC) / 1,000 to 2,000 mcg subcutaneously once weekly Standard dose (non-DAC, mod GRF 1-29) / 100 to 300 mcg subcutaneously daily Renal dosing data / no formal pharmacokinetic study in CKD populations Suggested CKD adjustment / reduce starting dose by 25 to 50% and extend intervals Key monitoring / serum IGF-1, eGFR, serum creatinine, fasting glucose every 4 to 6 weeks Regulatory status / investigational
Trimethylamine n-oxide supplementation abolishes the cardioprotective effects of voluntary exercise in mice fed a Western diet
Palmer SC, Tendal B, Mustafa RA, et al
Morning versus evening injection Clinical trials show no statistically significant difference in weight loss outcomes between morning and evening GLP-1 injections
GLP-1 receptor agonists are prescribed for type 2 diabetes when other treatments are inadequate or unsuitable, according to NICE guidelines